Gregory Scott Duncan - 16 Sep 2025 Form 4 Insider Report for CorMedix Inc. (CRMD)

Reporting relationship: Director
Issuer ticker: CRMD
Reported as of: 16 Sep 2025
Net transaction value: +$110,931
SEC form: 4
Accepted by SEC: 18 Sep 2025, 21:45:02 UTC
Prior SEC filing: 01 Jul 2025
Next SEC filing: 05 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Gregory Scott Duncan

Key filing fact

Gregory Scott Duncan filed Form 4 for CorMedix Inc. (CRMD) on 18 Sep 2025.

Key facts

This page summarizes Gregory Scott Duncan's Form 4 filing for CorMedix Inc. (CRMD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Sep 2025, 21:45.

Change

Previous filing in this sequence was filed on 01 Jul 2025.
Current net transaction value: +$110,931.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001831127 Primary reporting owner

Duncan Gregory Scott

Relationship: Director
Address: C/O CORMEDIX INC.,, 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS
Signature: /s/ Gregory Scott Duncan
Signature date: 18 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRMD transaction

Common Stock

Options Exercise

Transaction value: $110,931
Shares: +13,333
Change %: +53%
Price: $8.32
Shares after: 38,333
Date: 16 Sep 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRMD transaction Derivative

Stock Option (Right to Buy Common Stock)

Options Exercise

Transaction value: $0
Shares: -13,333
Change %: -67%
Price: $0.000000
Shares after: 6,667
Date: 16 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,333
Exercise price: $8.32
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.